Ricevi le ultime notizie sulle azioni Vericel con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di VCEL

Ultime notizie per

VERICEL CORP

Vericel

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Vericel Corp

Press Releases

Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025

Earnings

Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results

News

Vericel to Present at Multiple Upcoming Investor Conferences

Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025

Health Care

Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025

Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025

Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025

Vericel Reports Second Quarter 2025 Financial Results

Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025

VCEL

Ardelyx

Aurinia Pharmaceuticals Inc - Common Shares

Aurinia Pharmaceuticals

BioCryst Pharmaceuticals, Inc. - Common Stock

BioCryst Pharma

Biohaven

Celcuity

Celldex Therapeutics, Inc. - Common Stock

Celldex Therapeutics

Cogent Biosciences

Dianthus Therapeutics, Inc. - Common Stock

Dianthus Therapeutics

Dyne Therapeutics

Immunocore Holdings plc - American Depositary Shares

Immunocore Holdings

Janux Therapeutics

MannKind

NuCana

Novavax

Arcus Biosciences

Sionna Therapeutics

Syndax Pharmaceuticals, Inc. - Common Stock

Syndax Pharmaceuticals

Stoke Therapeutics

Tourmaline Bio

Taysha Gene Therapies, Inc. - Common Stock

Taysha Gene Therapies

Travere Therapeutics, Inc. - Common Stock

Travere Therapeutics

Twist Bioscience Corporation - Common Stock

Twist Bioscience

Vera Therapeutics, Inc. - Class A Common Stock

Vera Therapeutics

Viridian Therapeutics, Inc. - Common Stock

Comments

Vericel Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO